Investors Win Class Cert. Against Failed COVID Test Maker
Investors suing biotech company Talis Biomedical Corp. have received class certification in a suit alleging the company hurt investors when trading prices sank a month after its initial public offering when...To view the full article, register now.
Already a subscriber? Click here to view full article